News by Subject Medicine & Health

A new artificial intelligence-based score considers multiple factors to predict the prognosis of individual patients with COVID-19 seen at urgent care clinics or emergency departments. The tool, which was created by investigators at Massachusetts General Hospital, can be used to rapidly and automatically determine which patients are most likely to develop complications and need to be hospitalized.

A Morgridge imaging study of macrophages -- immune cells that are important to human health, but paradoxically can help some cancers grow and spread -- is offering better ways to understand these cells and target them with immunotherapies.

In a new study presented at the ASHG 2020 Virtual Meeting, researchers investigated the prevalence of disease-causing variants in established breast cancer predisposition genes in women over age 65.

An analysis of information from a large U.S. cancer database indicates that patients with liver cancer from rural regions and lower income households often have more advanced cancer at the time of diagnosis and face a higher risk of death compared with other patients. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society (ACS).

Researchers develop a new method to isolate specific cells, and in the process find a more robust fluorescent protein.

A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular with an interdisciplinary team of clinicians and researchers from FMUL and CHLN and collaborators at IPST, shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19. These results, now published in the scientific journal European Journal of Immunology, also show that age is not a confounding factor in levels of antibodies produced, but disease severity is.